Corticosteroids That Do Not Cross the Placenta
Prednisolone and prednisone are the preferred corticosteroids during pregnancy as they are largely metabolized by the placenta before reaching the fetus, with approximately 90% inactivation by placental 11β-hydroxysteroid dehydrogenase type 2 (11β-HSD2) enzyme. 1, 2
Placental Transfer of Different Corticosteroids
Non-Fluorinated Corticosteroids (Limited Placental Transfer)
Prednisolone/Prednisone:
- Cross the placenta at only about 10% of maternal concentration 2
- Placental 11β-HSD2 enzyme converts active prednisolone to inactive prednisone 3
- Fetal prednisolone levels are approximately 10-fold lower than maternal levels 2
- Strongly recommended for use during pregnancy when corticosteroids are needed 1
Hydrocortisone:
Fluorinated Corticosteroids (Significant Placental Transfer)
Dexamethasone and Betamethasone:
- Readily cross the placenta with minimal inactivation 1, 4
- Not inactivated by placental 11β-HSD2 enzyme 1
- Used specifically when fetal exposure is desired (e.g., fetal lung maturation) 1
- Should be avoided for maternal disease treatment during pregnancy 1
- Repeated doses associated with neurocognitive and neurosensory disorders in offspring 1
Budesonide and Fluticasone:
Clinical Recommendations for Corticosteroid Use in Pregnancy
For Maternal Disease Treatment
First Choice: Prednisolone or prednisone at lowest effective dose
For Inhaled Corticosteroids:
Important Considerations
Monitor for maternal complications:
Neonatal considerations:
Summary
When treating maternal conditions during pregnancy, prednisolone and prednisone are the preferred corticosteroids due to their limited placental transfer. Fluorinated corticosteroids (dexamethasone and betamethasone) should be reserved for situations where fetal exposure is specifically desired, such as promoting fetal lung maturity in threatened preterm birth.